BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3181252)

  • 1. Nuclear oncogene amplification or rearrangement is not involved in human colorectal malignancies.
    Dolcetti R; De Re V; Viel A; Pistello M; Tavian M; Boiocchi M
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1321-8. PubMed ID: 3181252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-myc oncogene expression in colorectal cancer.
    Sikora K; Chan S; Evan G; Gabra H; Markham N; Stewart J; Watson J
    Cancer; 1987 Apr; 59(7):1289-95. PubMed ID: 3545431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of cellular oncogene rearrangement or amplification in ovarian adenocarcinomas.
    Smith DM; Groff DE; Pokul RK; Bear JL; Delgado G
    Am J Obstet Gynecol; 1989 Oct; 161(4):911-5. PubMed ID: 2801838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma.
    Rothberg PG; Spandorfer JM; Erisman MD; Staroscik RN; Sears HF; Petersen RO; Astrin SM
    Br J Cancer; 1985 Oct; 52(4):629-32. PubMed ID: 4063140
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of c-myc oncogene expression and amplification in colorectal cancer.
    Wang J; Li L; Li S; Cui H; Shen G
    Chin Med Sci J; 1994 Mar; 9(1):24-8. PubMed ID: 8086630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene.
    Erisman MD; Rothberg PG; Diehl RE; Morse CC; Spandorfer JM; Astrin SM
    Mol Cell Biol; 1985 Aug; 5(8):1969-76. PubMed ID: 3837853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
    Smith DR; Myint T; Goh HS
    Br J Cancer; 1993 Aug; 68(2):407-13. PubMed ID: 8347498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli.
    Rothberg PG
    Semin Surg Oncol; 1987; 3(3):152-8. PubMed ID: 2821605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
    Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
    Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
    Saksela K; Bergh J; Nilsson K
    J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amplification of myc-specific sequences in human colonic cancer].
    Serova OM; Shpatar' TV; Fedorov SN; Kniazev PG; Novikov LB
    Vopr Onkol; 1986; 32(8):89-92. PubMed ID: 3765514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis.
    Wyllie FS; Lemoine NR; Williams ED; Wynford-Thomas D
    Br J Cancer; 1989 Oct; 60(4):561-5. PubMed ID: 2803926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance.
    Gutman M; Ravia Y; Assaf D; Yamamoto T; Rozin R; Shiloh Y
    Int J Cancer; 1989 Nov; 44(5):802-5. PubMed ID: 2573579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene alterations in primary human colon tumors.
    Alexander RJ; Buxbaum JN; Raicht RF
    Gastroenterology; 1986 Dec; 91(6):1503-10. PubMed ID: 2876925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.
    Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M
    Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.
    Jones DJ; Ghosh AK; Moore M; Schofield PF
    Br J Cancer; 1987 Dec; 56(6):779-83. PubMed ID: 3325094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
    Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
    Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines.
    Erisman MD; Scott JK; Watt RA; Astrin SM
    Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel combination of c-myc, N-myc and N-ras oncogene alteration in brain tumors.
    Sauceda R; Ocadiz R; Gutierrez AL; Salcedo M; Ortega V; Figueroa HH; Gariglio P
    Brain Res; 1988 Apr; 427(2):123-32. PubMed ID: 2838125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.